|
Herceptin is given based upon HER2 status, which is a characteristic of the type of cancer. Lymphnode testing to done to determine how far the cancer has potentially spread. I did not have lymphnode involvement and had both IDC and DCIS. I received Herceptin b/c I was her2 positive. It would follow that you should be getting Herceptin if you are Her2 positive.
I have not been following Tykerb as closely, but it is similar to Herceptin in that it attacks Her2 cancers. I am not sure, according to protocol, who is eligible for Tykerb, however, I believe it is used for more advanced cancers at this time.
Ask you onc what your Her2 status is again, in case there was a miscommunication. You may want a copy of your pathology report if you do not have it already.
- Shannon
__________________
Dx @ 29 years old in 8/05
Stage 1
2 IDC tumors (.7 cm and .5 cm)
4 cm DCIS
0 nodes
ER-/PR-
Her2+ (5.33 FISH)
AC (4 cycles)
Bi-lat mastectomy w/ lat flap recon + cohesive gel implants
1 year (every 3 weeks) Herceptin
|
Threaded Mode